Bioprotect
Now a part of Olympus, this medical technology company manufactures a biodegradable balloon spacer designed to protect the rectum during prostate cancer radiation therapy. The device creates a uniform, symmetrical space between the prostate and the anterior rectal wall to reduce radiation dose delivery to healthy tissue. The product is used by radiation oncologists and urologists performing SBRT, brachytherapy, and conventional radiotherapy treatments.
Healthtech
Medical Devices
Oncology
Funding summary
- Total raised
- €32.8M
- Funding rounds
- 2
Investors in Bioprotect
Investors on record for Bioprotect. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Bioprotect?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors